
About Charles River Laboratories India Private Limited
Data last updated:
Charles River Laboratories India Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Charles River Laboratories Holdings, France. It operates in the medical equipment retail and distribution segment of the healthcare sector. It was incorporated on 08 October 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24119KA2008PTC047975. Its GSTIN is 29AADCC4876C1ZL (Karnataka). The company holds 5 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹30.05 Cr and a paid-up capital of ₹28.79 Cr. It is led by directors including Prafulla Krishnaji Chitnis (Managing Director) and Rajesh Puthiya Sudhakaran (Managing Director).
Its last annual general meeting (AGM) was held on 23 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at No. 15 1st Floor Rest House Crescent Road, Bangalore, Karnataka, India – 560001.
As per the financials filed for FY 2025, the company reported a revenue of ₹99.82 Cr, a growth of 15% compared to the previous year. For the same year it recorded a net profit of ₹5.35 Cr (net margin 5.4%) and EBITDA of ₹7.95 Cr (EBITDA margin 8%). Revenue has grown at a compounded annual rate (CAGR) of 12% over three years and 10% over five years.
The company has about 85 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Charles River Laboratories and Cerebricon. Court records list 1 case involving the company, including 1 filed by the company. The company has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹28.78 Cr; the latest was in December 2008. Its 5 peer companies in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading) are compared by revenue, 2 larger and 3 smaller; the largest is G.S.Pharmaceutical Distributors Private Limited with revenue of ₹103.17 Cr.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website criver.com.
Company details
Contact details
Charles River Laboratories India Private Limited's registered office is in Bangalore, Karnataka. Its website is criver.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressNo. 15 1st Floor Rest House Crescent Road, Bangalore, Karnataka, India – 560001
- IndustryHealthcare, Medical Equipment Retail & Distribution
To see the full contact details of Charles River Laboratories India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Charles River Laboratories India operates two associated brands: Charles River Laboratories and Cerebricon. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provider of drug discovery and preclinical development services | criver.com | |
| Preclinical research services for CNS and PNS diseases are provided. | cerebricon.com |
Business activity
The main business activity of Charles River Laboratories India is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Charles River Laboratories India Private Limited, buy the company report.
Financials of Charles River Laboratories India Private Limited
FY 2025 filings availableCharles River Laboratories India Private Limited reported revenue of ₹99.82 Cr (up 15% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 10% over five years, including 15% growth in the latest year. EBITDA rose 167% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹7.95 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.35 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8% | ||||
| Net Profit Margin | 5.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Charles River Laboratories India Private Limited, buy the company report.
Board of directors of Charles River Laboratories India Private Limited
Charles River Laboratories India has 5 current directors and 18 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prafulla Krishnaji Chitnis | Managing Director | 02 Jan 2009 | 17 Years 10 Months | Current |
| Kevin John Finn | Director | 25 Aug 2022 | 4 Years 2 Months | Current |
| Jon Galli | Director | 13 Dec 2022 | 3 Years 11 Months | Current |
| Amro Elabbas | Additional Director | 11 Jun 2025 | 1 Years 5 Months | Current |
| Rajesh Puthiya Sudhakaran | Managing Director | 12 Jan 2026 | 0 Years 10 Months | Current |
Peer comparison
Charles River Laboratories India Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| G.S.Pharmaceutical Distributors Private Limited | ₹103.17 Cr (FY 2025) | 2.0% | Mumbai, Maharashtra, India | |||
| Esaote Asia Pacific Diagnostic Private Limited | ₹103.01 Cr (FY 2024) | 49.0% | New Delhi, Delhi, India | |||
| Charles River Laboratories India Private Limitedthis company | ₹99.82 Cr (FY 2025) | ₹5.35 Cr | 5.4% | 15.0% | 85 | Bangalore, Karnataka, India |
| Vishal Surgical Equipment Company Private Limited | ₹98.88 Cr (FY 2025) | 144.0% | Chennai, Tamil Nadu, India | |||
| Decent Medical Equipment Systems Private Limited | ₹98.24 Cr (FY 2025) | 21.0% | Indore, Madhya Pradesh, India | |||
| Jignesh Agency Private Limited | ₹98.17 Cr (FY 2025) | 1.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Charles River Laboratories India Private Limited, buy the company report.
Auditor
Charles River Laboratories India Private Limited is audited by Price Waterhouse & Co. for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Price Waterhouse & Co. | FY 2021 | 304026E/E300009 |
Shareholding
The shareholding of Charles River Laboratories India Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Charles River Laboratories India Private Limited, buy the company report.
Deals & funding
Charles River Laboratories India Private Limited has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹28.78 Cr; the latest was in December 2008.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Dec 2008 | Funding round | ₹28.78 Cr | Investors: Charles river Laboratories Holding, an individual |
| Nov 2008 | Secondary share transfer | Undisclosed | Buyer: Charles river Laboratories Holding, an individual Seller: 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Charles River Laboratories India Private Limited has 1 court case on record: 1 filed by Charles River Laboratories India. All case is disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Indore, Madhya Pradesh | Court case (UN CIV) | Filed by the company against M/S. Infutee Healthcare Limited | Disposed |
To see the full case history of Charles River Laboratories India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Charles River Laboratories India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Charles River Laboratories India Private Limited has a workforce of 85 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 85 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Charles River Laboratories India Private Limited, buy the company report.
GST
Charles River Laboratories India has 5 GST registrations: 4 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AADCC4876C1ZL | Karnataka | Active | 01 Jul 2017 |
| 24AADCC4876C1ZV | Gujarat | Active | 01 Jul 2017 |
| 27AADCC4876C1ZP | Maharashtra | Active | 01 Jul 2017 |
| 36AADCC4876C1ZQ | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Charles River Laboratories India Private Limited, buy the company report.
Recent activity
Charles River Laboratories India Private Limited has 19 board changes on record since 2008: 6 appointments and 13 cessations. The latest: Rajesh Puthiya Sudhakaran was appointed as Managing Director on 12 Jan 2026.
10 earlier events are in the company report.
News
Frequently asked questions
Charles River Laboratories India is an active private limited company based in Bangalore, Karnataka, India. The company works in medical equipment retail and distribution, within the healthcare industry. It was incorporated on 08 October 2008 (18+ years old) and is registered under CIN U24119KA2008PTC047975.
Charles River Laboratories India has 5 current directors:
- Prafulla Krishnaji Chitnis - Managing Director
- Rajesh Puthiya Sudhakaran - Managing Director
- Kevin John Finn - Director
- Jon Galli - Director
- Amro Elabbas - Additional Director
The latest financial statements of Charles River Laboratories India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 23 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Charles River Laboratories India is 29AADCC4876C1ZL, registered in Karnataka. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 24AADCC4876C1ZV (Gujarat), 27AADCC4876C1ZP (Maharashtra), 36AADCC4876C1ZQ (Telangana).
The CIN (Corporate Identification Number) of Charles River Laboratories India is U24119KA2008PTC047975. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Charles River Laboratories India has 1 court case on record: 1 filed by the company.
Charles River Laboratories India was incorporated on 08 October 2008, making it 18+ years old. It is registered with the Registrar of Companies, Bangalore.
Charles River Laboratories India has 2 deals on record (1 funding round, 1 secondary share transfer), with disclosed funding of ₹28.78 Cr; the latest was in December 2008.
The peers of Charles River Laboratories India by revenue are G.S.Pharmaceutical Distributors Private Limited, Esaote Asia Pacific Diagnostic Private Limited, Vishal Surgical Equipment Company Private Limited, Decent Medical Equipment Systems Private Limited, Jignesh Agency Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution), with the same principal business activity (wholesale trading).
Rajesh Puthiya Sudhakaran was appointed as Managing Director on 12 Jan 2026. Amro Elabbas was appointed as Additional Director on 11 Jun 2025. Jon Galli ceased to be Additional Director on 28 Sep 2023. Charles River Laboratories India has 19 board changes on record in total.
Charles River Laboratories India can be reached through the website criver.com. Its registered office is in Bangalore, Karnataka, India.

